TWO KIDNEY RECIPIENTS WITH GOOD FUNCTION AND DONOR SPECIFIC ANTIBODIES POSITIVE FOR C1Q AND IGG4 SUBCLASS

被引：0
|
作者：
Cicciarelli, James C. [1 ]
Lemp, Nathan A. [1 ,2 ]
Kasahara, Noriyuki [1 ]
Burns, Kevin
Williams, Bruce [3 ]
Bloom, Sheila [3 ]
Montes, Rolando [3 ]
Pitpitan, Bennie [1 ]
Brown, Barry [3 ]
Steinberg, Steven [1 ]
机构：
[1] Viracor IBT Labs, Los Angeles, CA USA
[2] BloodSource, Sacramento, CA USA
[3] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA
来源：
HUMAN IMMUNOLOGY | 2015年 / 76卷 / 04期
关键词：
D O I：
10.1016/j.humimm.2015.01.046
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
LBP14
引用
收藏
页码：222 / 222
页数：1
相关论文
共 50 条
  • [31] C1Q STATUS AND TITER OF DE NOVO DONOR SPECIFIC ANTIBODIES ARE NOT PREDICTORS OF ALLOGRAFT SURVIVAL
    Wiebe, Chris
    Gareau, Alison
    Pochinco, Denise
    Gibson, Ian
    Ho, Julie
    Birk, Patricia
    Blydt-Hansen, Tom
    Karpinski, Martin
    Goldberg, Aviva
    Storsley, Leroy
    Rush, David
    Nickerson, Peter
    HUMAN IMMUNOLOGY, 2016, 77 : 72 - 72
  • [32] PREVALENCE AND CLINICAL SIGNIFICANCE OF C1Q BINDING DONOR SPECIFIC ANTIBODIES IN RENAL TRANSPLANTATION.
    Colovai, Adriana
    Savchik, Christina
    Inal, Summeye Calp
    Masiakos, Peter
    Ling, Min
    Kayler, Liise
    Akalin, Enver
    HUMAN IMMUNOLOGY, 2014, 75 : 79 - 79
  • [33] Correlation of C1q Binding in Patients with Donor Specific HLA Antibodies and Post Transplant Rejection
    Saltarrelli, J.
    Lappin, J.
    Katz, S.
    Varga, K.
    Van Buren, C.
    Bihari, L.
    Cook, D.
    Tyan, D.
    Kerman, R.
    Chen, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 290 - 290
  • [34] CLINICAL RISK STRATIFICATION OF PAEDIATRIC RENAL TRANSPLANT RECIPIENTS USING C1Q AND C3D FIXING OF DONOR SPECIFIC ANTIBODIES.
    Kim, J. J.
    Shaw, O.
    Martin, C.
    Michaelides, G.
    Balasubramaniam, R.
    Sebire, N. J.
    Mamode, N.
    Dorling, A.
    Vaughan, R.
    Marks, S. D.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 42 - 42
  • [35] C1Q FIXING ABILITY OF DE NOVO DONOR SPECIFIC ANTIBODIES PREDICTS EARLY BUT NOT LONG-TERM KIDNEY ALLOGRAFT LOSS
    Guerville, F.
    Guidicelli, G. L.
    Lepreux, S.
    Merville, P.
    Taupin, J. L.
    Couzi, L.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 17 - 17
  • [36] Complement (C1q) Binding De Novo Donor-Specific Antibodies and Cardiac-Allograft Vasculopathy in Pediatric Heart Transplant Recipients
    Das, Bibhuti B.
    Lacelle, Chantale
    Zhang, Song
    Gao, Ang
    Fixler, David
    TRANSPLANTATION, 2018, 102 (03) : 502 - 509
  • [37] IGG SUBCLASS RESTRICTION OF AUTOANTIBODY TO SOLID-PHASE C1Q IN MEMBRANOPROLIFERATIVE AND LUPUS GLOMERULONEPHRITIS
    PRADA, AE
    STRIFE, CF
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 63 (01): : 84 - 88
  • [38] Outcomes of Kidney Transplant Recipients with ESRD Secondary to C1q Nephropathy
    Qazi, Yasir A.
    Qazi, Suhail H.
    Maqbool, Iffat
    Smogorzewski, Mirosolav
    Alexopoulus, Sophocles
    Genyk, Yuri
    Stapher, Maria
    Shidban, Hamid
    Sher, Linda
    Campese, Vito
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 527 - 527
  • [39] Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner
    Mehlhop, Erin
    Ansarah-Sobrinho, Camillo
    Johnson, Syd
    Engle, Michael
    Fremont, Daved H.
    Pierson, Theodore C.
    Diamond, Michael S.
    CELL HOST & MICROBE, 2007, 2 (06) : 417 - 426
  • [40] IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients
    Hamdani, Gilad
    Goebel, Jens W.
    Brailey, Paul
    Portwood, Elizabeth A.
    Hooper, David K.
    Girnita, Alin L.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (05)
12345